Indices in this article
NEW YORK (dpa-AFX) – The US stock markets were mostly in the red on Tuesday. The technology stocks on the Nasdaq were particularly under pressure. Only the standard values on Wall Street tended to be friendly. Traders spoke of troubled trading with low turnover and blamed profit-taking after the recent price rally for the setback. News of a record increase in coronavirus cases worldwide provided slightly negative impetus.
The Dow Jones Industrial (Dow Jones 30 Industrial) closed with an increase of 0.26 percent at 36 398.21 points. The S&P 500 lost 0.10 percent to 4786.35 points after hitting another record high in early trading. The tech-heavy NASDAQ 100 fell 0.48 percent to 16,488.66 points.
The sharp rise in Omicron infections brought the global Covid-19 cases to a daily high on Monday. Investors are reassured by studies that the Omicron variant is highly contagious, but causes less serious diseases, it said from the trade.
AlphaTrai’s investment strategist Max Gokhman attributed the downward trend to “gravity”. “There was no clear catalyst for the climb on Monday, so we’re giving some of it back today,” he said. “I don’t think today’s setback suggests any further declines, but this week’s seasonally low volume combined with stock-level volatility, unusually high for the time of year, means that a single wrong headline will result in a significant move in one way or another Direction when we embark on the final stage of 2021, “said Gokhman.
From an industry perspective, the airline shares, which were slacking the day before, caught the eye on Tuesday with recovery gains. The United Airlines and Delta Air Lines papers each gained 1.6 percent, while those of American Airlines advanced 2.0 percent. The US airlines canceled hundreds of flights over the Christmas weekend due to the rampant Coronavirus variant Omikron and massive bad weather.
The shares of Novavax used their more than ten percent starting gains in the course of trading completely and ended with a loss of 1.2 percent. Initially, the news was supported that the US vaccine manufacturer has now also received emergency approval for its Covid-19 vaccine from the Indian drug authorities. The Novavax corona vaccine has also been officially approved in the EU for a few days.
In US trading, the euro recovered somewhat from its clear loss in late European business and rose again above the US $ 1.13 mark. Most recently, the European common currency cost 1.1311 dollars. The European Central Bank had set the reference rate at 1.1331 (Monday: 1.1312) dollars. The dollar had thus cost 0.8825 (0.8840) euros.
US Treasuries rose moderately. The futures contract for ten-year Treasuries (T-Note-Future) recently advanced by 0.05 percent to 130.62 points. The yield on ten-year government bonds stood at 1.48 percent./edh/he
–
